Literature DB >> 3081721

Correlation of the in vitro cytotoxic and in vivo antitumor activities of gold(I) coordination complexes.

C K Mirabelli, R K Johnson, D T Hill, L F Faucette, G R Girard, G Y Kuo, C M Sung, S T Crooke.   

Abstract

A series of gold(I) coordination complexes including analogues of the antiarthritic agent auranofin 1 were evaluated for in vitro cytotoxic potency against both B16 melanoma cells and P388 leukemia cells and in vivo antitumor activity against P388 leukemia in mice. A number of the complexes showed potent cytotoxic activity in vitro and antitumor activity in vivo, with the phosphine-coordinated gold(I) thiosugar complexes demonstrating the greatest in vitro and in vivo activity. The data compiled for 63 complexes of the general structural formula LAuX provide the basis for the following observations: potent in vitro cytotoxic activity is observed for substituted (phosphine) gold complexes, lack of potency in vitro correlates well with lack of antitumor activity, potent cytotoxicity in vitro is not necessarily predictive of activity in vivo, in vivo antitumor activity is generally optimized by ligation of Au(I) with a substituted phosphine and a thiosugar.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3081721     DOI: 10.1021/jm00152a009

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  21 in total

1.  Gold-containing indoles as anticancer agents that potentiate the cytotoxic effects of ionizing radiation.

Authors:  Sandra Craig; Lei Gao; Irene Lee; Thomas Gray; Anthony J Berdis
Journal:  J Med Chem       Date:  2012-02-15       Impact factor: 7.446

2.  Dithiocarbamate-based coordination compounds as potent proteasome inhibitors in human cancer cells.

Authors:  Daniela Buac; Sara Schmitt; George Ventro; Fathima Rani Kona; Q Ping Dou
Journal:  Mini Rev Med Chem       Date:  2012-10       Impact factor: 3.862

Review 3.  Deubiquitinases (DUBs) and DUB inhibitors: a patent review.

Authors:  Pershang Farshi; Rahul R Deshmukh; Joseph O Nwankwo; Richard T Arkwright; Boris Cvek; Jinbao Liu; Q Ping Dou
Journal:  Expert Opin Ther Pat       Date:  2015-06-16       Impact factor: 6.674

4.  Replacement of the Thiosugar of Auranofin with Iodide Enhances the Anticancer Potency in a Mouse Model of Ovarian Cancer.

Authors:  Tiziano Marzo; Lara Massai; Alessandro Pratesi; Matteo Stefanini; Damiano Cirri; Francesca Magherini; Matteo Becatti; Ida Landini; Stefania Nobili; Enrico Mini; Olivia Crociani; Annarosa Arcangeli; Serena Pillozzi; Tania Gamberi; Luigi Messori
Journal:  ACS Med Chem Lett       Date:  2019-02-07       Impact factor: 4.345

5.  Gold(I) NHC-based homo- and heterobimetallic complexes: synthesis, characterization and evaluation as potential anticancer agents.

Authors:  Benoît Bertrand; Anna Citta; Inge L Franken; Michel Picquet; Alessandra Folda; Valeria Scalcon; Maria Pia Rigobello; Pierre Le Gendre; Angela Casini; Ewen Bodio
Journal:  J Biol Inorg Chem       Date:  2015-07-23       Impact factor: 3.358

6.  Auranofin, Et3PAuCl, and Et3PAuI Are Highly Cytotoxic on Colorectal Cancer Cells: A Chemical and Biological Study.

Authors:  Tiziano Marzo; Damiano Cirri; Chiara Gabbiani; Tania Gamberi; Francesca Magherini; Alessandro Pratesi; Annalisa Guerri; Tarita Biver; Francesca Binacchi; Matteo Stefanini; Annarosa Arcangeli; Luigi Messori
Journal:  ACS Med Chem Lett       Date:  2017-09-06       Impact factor: 4.345

7.  The tumor proteasome as a novel target for gold(III) complexes: implications for breast cancer therapy.

Authors:  Vesna Milacic; Q Ping Dou
Journal:  Coord Chem Rev       Date:  2009       Impact factor: 22.315

8.  N-Heterocyclic Carbene-Gold(I) Complexes Conjugated to a Leukemia-Specific DNA Aptamer for Targeted Drug Delivery.

Authors:  Weijia Niu; Xigao Chen; Weihong Tan; Adam S Veige
Journal:  Angew Chem Int Ed Engl       Date:  2016-06-17       Impact factor: 15.336

Review 9.  New applications of old metal-binding drugs in the treatment of human cancer.

Authors:  Sara M Schmitt; Michael Frezza; Qing Ping Dou
Journal:  Front Biosci (Schol Ed)       Date:  2012-01-01

10.  Evaluating Ligand Modifications of the Titanocene and Auranofin Moieties for the Development of More Potent Anticancer Drugs.

Authors:  Lauren Fernandez-Vega; Valeria A Ruiz Silva; Tania M Domínguez-González; Sebastián Claudio-Betancourt; Rafael E Toro-Maldonado; Luisa C Capre Maso; Karina Sanabria Ortiz; Jean A Pérez-Verdejo; Janeishly Román González; Grecia T Rosado-Fraticelli; Fabiola Pagán Meléndez; Fabiola M Betancourt Santiago; Daniel A Rivera-Rivera; Carlos Martínez Navarro; Andrea C Bruno Chardón; Axel O Vera; Arthur D Tinoco
Journal:  Inorganics (Basel)       Date:  2020-01-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.